First Time Loading...
I

Intra-Cellular Therapies Inc
NASDAQ:ITCI

Watchlist Manager
Intra-Cellular Therapies Inc
NASDAQ:ITCI
Watchlist
Price: 69.44 USD -1.28%
Updated: May 3, 2024

Intra-Cellular Therapies Inc
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Intra-Cellular Therapies Inc
Cash from Investing Activities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
I
Intra-Cellular Therapies Inc
NASDAQ:ITCI
Cash from Investing Activities
$105.5m
CAGR 3-Years
N/A
CAGR 5-Years
-5%
CAGR 10-Years
53%
Johnson & Johnson
NYSE:JNJ
Cash from Investing Activities
$878m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bristol-Myers Squibb Co
NYSE:BMY
Cash from Investing Activities
-$21.7B
CAGR 3-Years
-23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Cash from Investing Activities
-$32.3B
CAGR 3-Years
-96%
CAGR 5-Years
N/A
CAGR 10-Years
-12%
Merck & Co Inc
NYSE:MRK
Cash from Investing Activities
-$14.1B
CAGR 3-Years
-18%
CAGR 5-Years
N/A
CAGR 10-Years
-9%
Eli Lilly and Co
NYSE:LLY
Cash from Investing Activities
-$7.2B
CAGR 3-Years
-47%
CAGR 5-Years
N/A
CAGR 10-Years
-13%

See Also

What is Intra-Cellular Therapies Inc's Cash from Investing Activities?
Cash from Investing Activities
105.5m USD

Based on the financial report for Dec 31, 2023, Intra-Cellular Therapies Inc's Cash from Investing Activities amounts to 105.5m USD.

What is Intra-Cellular Therapies Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
53%